Praxis Precision Medicines has reported encouraging results from its first-in-human clinical trial of vormatrigine (PRAX-628), a novel drug being developed for epilepsy treatment. This session

A groundbreaking clinical trial has been launched to evaluate BHV-7000, a novel treatment for idiopathic generalized epilepsy (IGE) with generalized tonic-clonic seizures, using an innovative

A groundbreaking long-term clinical trial has demonstrated that brivaracetam, when used as an add-on therapy, shows sustained effectiveness and safety in children suffering from primary

A major clinical trial has begun testing a promising new treatment for one of the most challenging forms of epilepsy. Harmony Biosciences has launched a

A recent meta-analysis published in the journal Neurology has uncovered significant connections between common anti-seizure medications (ASMs) and potentially dangerous changes in patients’ lipid profiles.

A groundbreaking study presented at the 2025 American Academy of Neurology annual meeting has revealed that an extended-release oral formulation of carbidopa-levodopa substantially improves sleep

A promising new systematic review has found that cryoneurolysis, a technique that uses extreme cold to temporarily disable nerves, may offer significant relief for the

A case series has revealed that a minimally invasive nasal procedure may offer rapid relief for patients suffering from debilitating trigeminal neuralgia flares. The research,

A investigationa clinical trial has revealed promising results for an innovative cell therapy approach to treating drug-resistant temporal lobe epilepsy. The study was presented on

A long-term study has revealed encouraging safety and efficacy data for azetukalner (XEN1101), an innovative anti-seizure medication designed for adults with difficult-to-treat focal epilepsy. The